-
Subject Areas on Research
-
A pharmacy management intervention for optimizing drug therapy for nursing home patients.
-
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.
-
A systematic review of treatments for refractory depression in older people.
-
Addressing Polypharmacy in Older Adults Living With HIV.
-
Adverse drug events in high risk older outpatients.
-
Adverse drug reaction risk factors in older outpatients.
-
Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
-
Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation.
-
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
-
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.
-
Clinical Update on Nursing Home Medicine: 2016.
-
Clinicians' utilization of child mental health telephone consultation in primary care: findings from Massachusetts.
-
Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
-
Common comorbidity scales were similar in their ability to predict health care costs and mortality.
-
Community-Based Malaria Testing Reduces Polypharmacy in a Population-Based Survey of Febrile Illness in Western Kenya.
-
Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China.
-
Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients.
-
Deprescribing medications: Do out-of-pocket costs have a role?
-
Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapy.
-
Drug-drug interactions in older adults: which ones matter?
-
Effectiveness of switching from antipsychotic polypharmacy to monotherapy.
-
Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.
-
Evaluation of Risk Factors for Antipsychotic Polypharmacy in Inpatient Psychiatry Units of a Community Hospital: A Retrospective Analysis.
-
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
-
High Prevalence of Fall-Related Medication Use in Older Veterans at Risk for Falls.
-
Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation.
-
Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders.
-
Inappropriate drug use among community-dwelling elderly.
-
Measuring Underuse and Overuse of Medications.
-
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.
-
Medication Use Quality and Safety in Older Adults: 2019 Update.
-
Medication use quality and safety in older adults: 2020 update.
-
Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
-
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association.
-
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial.
-
Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population.
-
Perspectives on Implementing a Multidomain Approach to Caring for Older Adults With Heart Failure.
-
Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
-
Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients.
-
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
-
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
-
Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.
-
Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience.
-
Polypharmacy in patients with advanced cancer and the role of medication discontinuation.
-
Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
-
Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.
-
Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.
-
Prescriber Continuity and Disease Control of Older Adults.
-
Prescriber continuity and medication adherence for complex patients.
-
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
-
Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants.
-
Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
-
QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.
-
Quantifying the utility of taking pills for cardiovascular prevention.
-
Randomized Controlled Trial of Screening, Risk Modification, and Physical Therapy to Prevent Falls Among the Elderly Recently Discharged From the Emergency Department to the Community: The Steps to Avoid Falls in the Elderly Study.
-
Recent Literature Update on Medication Risk in Older Adults, 2015-2016.
-
Reducing medication regimen complexity: a controlled trial.
-
Reducing polypharmacy: evidence from a simple quality improvement initiative.
-
Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
-
The Burden of Overmedication: What Are the Real Issues?
-
The Burden of Polypharmacy in Patients Near the End of Life.
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
-
Treatment considerations for elderly and frail patients with neuropathic pain.
-
Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study.
-
Unnecessary drug use in frail older people at hospital discharge.
-
Update on Medication Use Quality and Safety in Older Adults, 2017.
-
Updates in nutrition and polypharmacy.
-
Usability of mobile technology to screen for drug-drug interactions in kidney transplant patients.
-
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease.
-
Use of psychotropic medications by youths in therapeutic foster care and group homes.
-
What types of inappropriate prescribing predict adverse drug reactions in older adults?
-
Whatever happened to the polypill?
-
Keywords of People